01226nas a2200277   4500000000100000008004100001260001300042653001500055653001000070653002000080653001100100653001100111653001300122653001200135653001500147653000900162653001600171100001100187700001500198245012100213300000900334490000700343050003200350520055200382022001400934       1983                            d  c1983 Jan10aAdolescent10aAdult10aDrug Evaluation10aFemale10aHumans10aLepromin10aleprosy10aLevamisole10aMale10aMiddle Aged1 aRamu G1 aSengupta U00aPreliminary trial of intervention levamisole therapy in persistently bacteriologically positive lepromatous leprosy.  a64-70 v55  aInfolep Library - available3 a<p>The intervention treatment with the immuno-adjuvant levamisole was given in 14 persistently bacteriologically positive lepromatous cases who had had adequate chemotherapy for over 5 years. There was a temporary conversion of the early lepromin reaction in a majority of the patients with a corresponding improvement in clinical and bacteriological status. However, the lepromin response was short lived. Most patients had become bacteriologically negative at the end of 1 year. No adverse effects due to levamisole therapy were encountered.</p>  a0024-1024